SCHEMBL320232

SCHEMBL320232

CC(O)C(=O)OCC(O)CO

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
KDM4E B2RXH2 2/20 0.48
DUSP3 P51452 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
DGKA P23743 1/20 0.41
FAAH O00519 2/20 0.39
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 2/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AGTR1 P30556 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30531662 1.00 LMNA (0.48) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL31683702 1.00 LMNA (0.48) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL4836149 0.98 LMNA (0.47) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL7960059 0.98 LMNA (0.47) LMNAKDM4EDUSP3MEN1KMT2A
Lactic Acid SCHEMBL28460211 0.94 TP53 (0.46) LMNAKDM4EDUSP3MEN1KMT2A
Hexadecane SCHEMBL28029400 0.88 KDM4E (0.67) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL3635596 0.86 LMNA (0.48) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL4729415 0.86 KDM4E (0.42) LMNAKDM4EDUSP3MEN1KMT2A
Butyric Acid SCHEMBL27902376 0.85 KDM4E (0.50) LMNAKDM4EDUSP3MEN1KMT2A
Citric Acid SCHEMBL30003489 0.82 ALDH1A1 (0.48) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 683 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144726-A1 POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2026-05-28 US claimed
US-20260137651-A1 MULTI-COMPARTMENT NANOEMULSION FOR INTRANASAL DRUG DELIVERY KING ABDULAZIZ UNIVERSITY (SA) 2026-05-21 US claimed
US-12599572-B2 Solid lipid nanoparticles of curcumin Punjab University Chandigarh (IN) 2026-04-14 US claimed
EP-4687490-A1 ENZYME COMPOSITION AND BEER BREWING PROCESS DSM IP Assets B.V. (NL) 2026-02-11 EP claimed
EP-4686433-A1 STARCH FURNITURE EDGING TAPE FOR VENEERING NARROW PLANES OF FURNITURE ELEMENTS MADE OF WOOD-BASED BOARD Ecoedge Sp. z o.o. (PL) 2026-02-04 EP claimed
CN-119867010-A Egg rich in DHA nutrients and production method thereof 青岛藻源海洋生物科技有限公司 2025-04-25 CN claimed
CN-119661953-A Temperature-resistant modified floor film and preparation method thereof 宿迁浔泽木业有限公司 2025-03-21 CN claimed
CN-119605996-A Biphase gel loaded with natural antioxidants and preparation method and application thereof 江南大学 2025-03-14 CN claimed
CN-119563721-A Composite cream and preparation method thereof 中粮营养健康研究院有限公司 2025-03-07 CN claimed
CN-119111416-A Mixed-dimension attapulgite clay-based multifunctional environment regulator for cultivation and preparation method thereof 中国科学院兰州化学物理研究所 2024-12-13 CN claimed
US-6814953-B2 FORMOTEROL, OR A DERIVATIVE; LONG TERM STORAGE STABILITY DEY L.P. 2004-11-09 US claimed
US-20040136928-A1 Compositions for removing stains from dental surfaces, and methods of making and using the same HOLME SAMANTHA K (US) 2004-07-15 US claimed
WO-2004039277-A2 COMPOSITIONS FOR REMOVING STAINS FROM DENTAL SURFACES CADBURY ADAMS USA LLC (US) 2004-05-13 WO claimed
US-6685916-B1 CHEWING GUM AND CONFECTIONERIES, DESIRABLE ORGANOLEPTIC AND TASTE PROPERTIES; A PEROXIDE COMPOUND, A POLYPHOSPHATE, AND AN ANIONIC SURFACTANT CADBURY ADAMS USA LLC 2004-02-03 US claimed
EP-0737425-B1 Oil-in-water emulsion containing lysophospholipo-proteins ASAHI DENKA KOGYO KK (JP) 2001-09-12 EP claimed
US-5456746-A Gelatin containing ester of fatty acid and glycerol; reduces cracking, chipping, leakage of capsules WARNER-LAMBERT COMPANY (US) 1995-10-10 US claimed
EP-0600422-A1 Hard film composition for capsules WARNER-LAMBERT COMPANY (US) 1994-06-08 EP claimed
EP-0287652-A4 SERUM-FREE MEDIUM FOR THE PROLIFERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS. LIFE TECHNOLOGIES INC (US) 1990-01-08 EP claimed
EP-0287652-A1 SERUM-FREE MEDIUM FOR THE PROLIFERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS. LIFE TECHNOLOGIES INC (US) 1988-10-26 EP claimed
WO-1988002774-A1 SERUM-FREE MEDIUM FOR THE PROLIFERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS LIFE TECHNOLOGIES, INC. (US) 1988-04-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144726-A1 POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER HAO2, HADH, LDHA LMNA 1256/4885KDM4E 2500/4885DUSP3 4596/4885
US-20260137651-A1 MULTI-COMPARTMENT NANOEMULSION FOR INTRANASAL DRUG DELIVERY NAPEPLD, LIPA, SCD LMNA 1200/4885KDM4E 2457/4885DUSP3 1575/4885
US-12599572-B2 Solid lipid nanoparticles of curcumin CPT1A, CPT2, SCD LMNA 528/4885KDM4E 491/4885DUSP3 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.